T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$2.57B |
| 2 |
GE Aerospace
GE
|
+$1.8B |
| 3 |
UnitedHealth
UNH
|
+$1.63B |
| 4 |
Marriott International
MAR
|
+$1.62B |
| 5 |
Apple
AAPL
|
+$1.3B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$2.87B |
| 2 |
JPMorgan Chase
JPM
|
+$1.64B |
| 3 |
Nike
NKE
|
+$1.59B |
| 4 |
Becton Dickinson
BDX
|
+$1.46B |
| 5 |
Alibaba
BABA
|
+$1.32B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.97% |
| 2 | Healthcare | 18.52% |
| 3 | Consumer Discretionary | 13.26% |
| 4 | Financials | 12.08% |
| 5 | Communication Services | 10.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1151
United Rentals
URI
$70.3B
| $15.2M | ﹤0.01% |
147,534
-1,680,321
| -92% | -$223M |
|
|
IPG
1152
DELISTED
Interpublic Group of Companies
IPG
| $15.2M | ﹤0.01% |
937,585
+61,632
| +7% | +$1.3M |
|
1153
Globe Life
GL
$13.8B
| $15.1M | ﹤0.01% |
209,285
+9,592
| +5% | +$904K |
|
|
MCF
1154
DELISTED
Contango Oil & Gas Co.
MCF
| $15M | ﹤0.01% |
10,002,390
| – | – |
|
|
CDR
1155
DELISTED
Cedar Realty Trust, Inc
CDR
| $15M | ﹤0.01% |
2,434,899
+9,184
| +0.4% | +$142K |
|
|
RWT
1156
Redwood Trust
RWT
$592M
| $14.8M | ﹤0.01% |
2,931,179
+541,759
| +23% | +$8.06M |
|
1157
W.R. Berkley
WRB
$25.9B
| $14.5M | ﹤0.01% |
625,655
+53,127
| +9% | +$1.58M |
|
1158
Steel Dynamics
STLD
$37.7B
| $14.5M | ﹤0.01% |
641,977
+51,398
| +9% | +$1.41M |
|
|
ALLK
1159
DELISTED
Allakos
ALLK
| $14.5M | ﹤0.01% |
325,097
-78,283
| -19% | -$5.35M |
|
|
BMY.RT
1160
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| $14.4M | ﹤0.01% |
3,799,745
-201,100
| -5% | -$662K |
|
|
PVBC
1161
DELISTED
Provident Bancorp
PVBC
| $14.4M | ﹤0.01% |
1,674,990
+821,634
| +96% | +$9.08M |
|
1162
Universal Insurance Holdings
UVE
$1.18B
| $14.3M | ﹤0.01% |
798,882
-10,796
| -1% | -$248K |
|
|
LOGM
1163
DELISTED
LogMein, Inc.
LOGM
| $14.3M | ﹤0.01% |
171,187
-121,679
| -42% | -$10.3M |
|
1164
Phibro Animal Health
PAHC
$1.37B
| $14.2M | ﹤0.01% |
587,927
-3,071
| -0.5% | -$75K |
|
|
HA
1165
DELISTED
Hawaiian Holdings, Inc.
HA
| $14.2M | ﹤0.01% |
1,359,679
-696,722
| -34% | -$15.9M |
|
1166
NRG Energy
NRG
$25.4B
| $14M | ﹤0.01% |
513,244
+52,576
| +11% | +$1.81M |
|
1167
Pacira BioSciences
PCRX
$924M
| $14M | ﹤0.01% |
417,069
-2,052
| -0.5% | -$85.2K |
|
|
TECX
1168
Tectonic Therapeutic
TECX
$720M
| $13.9M | ﹤0.01% |
74,545
-5,250
| -7% | -$1.24M |
|
1169
Ponce Financial Group
PDLB
$500M
| $13.9M | ﹤0.01% |
1,890,070
-24,834
| -1% | -$238K |
|
1170
Baker Hughes
BKR
$63B
| $13.9M | ﹤0.01% |
1,319,108
+103,880
| +9% | +$1.95M |
|
|
AGFS
1171
DELISTED
AgroFresh Solutions Inc
AGFS
| $13.6M | ﹤0.01% |
8,303,917
-37,401
| -0.4% | -$80.4K |
|
1172
Sixth Street Specialty
TSLX
$1.79B
| $13.5M | ﹤0.01% |
972,827
-381,234
| -28% | -$7.7M |
|
1173
HF Sinclair
DINO
$15.6B
| $13.4M | ﹤0.01% |
545,893
+32,810
| +6% | +$1.23M |
|
1174
JELD-WEN Holding
JELD
$164M
| $13.4M | ﹤0.01% |
1,374,524
+239,356
| +21% | +$4.77M |
|
1175
Kinross Gold
KGC
$32.6B
| $13.4M | ﹤0.01% |
3,363,534
+488,399
| +17% | +$2.36M |
|
Similar funds
T. Rowe Price Associates's Q1 2020 Portfolio in Review
As of Q1 2020, T. Rowe Price Associates held 2,612 positions worth $632B, down 18% from $771B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2020 filing shows 87 new, 1,525 increased, 823 reduced and 103 closed positions. Its largest new stake was Philips: 33,363,001 shares worth $1.07B. The largest sale was Boeing, an estimated $2.87B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2020 buy was Philips: 33,363,001 shares worth $1.07B.
- T. Rowe Price Associates added most to Humana in Q1 2020, an estimated $2.57B increase.
- T. Rowe Price Associates's biggest Q1 2020 reduction was Boeing, cutting an estimated $2.87B.
- T. Rowe Price Associates fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $846M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $632B portfolio in Q1 2020.
- T. Rowe Price Associates opened 87 new positions and closed 103 in Q1 2020.
- T. Rowe Price Associates's portfolio value fell 18% quarter-over-quarter to $632B.
Based on T. Rowe Price Associates's 13F filing for Q1 2020, filed 15 May 2020.